Phase I study of preoperative Docetaxel, Cisplatin and S-1 for patients with advanced gastric cancer
Phase 1
- Conditions
- Patients with unresectable gastric cancer due to limited invasion and/or metastasis.
- Registration Number
- JPRN-UMIN000001025
- Lead Sponsor
- Dept. of Gastroenterologic Surgery, Kanazawa University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1. Active infection 2. Other severe complications 3. Active double cancer 4. CNS metastasis 5. Pericardiac fluid 6. Mortor paralysis or peripheral neural disturbance. 7. History of severe allergy against drug. 8. Severe peritoneal metastasis 9. Pregnant women or women who like to be pregnant. 10. Doctor' s dicision not to be registered to this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Adverse events Ratio of complete treatment Response rate of preoperative chemotherapy